Keyword: NIAID

Zika vaccine research continues in the absence of a large-scale outbreak, but a shortage of cases is making it hard to test for efficacy.

Here is some other vaccine news of note for the week.

Johnson & Johnson's "mosaic" HIV vaccine regimen elicited immune responses one year after the final shot.

Here is some other vaccine news of note for the week.

Here is some other vaccine news of note for the week.

Here is some other vaccine news of note for the week.

Inovio's HIV vaccine is in early-stage development, but the company reported immune responses induced by the shot that lasted at least six months.

BiondVax enrolled its first patient in a phase 2 U.S. study of its universal flu vaccine, which aims to fight off all strains of the virus at the same time.

Here is some other vaccine news of note for the week.

Experts say technology is advancing to develop vaccines faster at a time of increasing emerging disease outbreaks.